Heart Failure - Cause, Pathophysiology, Management With MCQs Practice

HEART FAILURE (CONGESTIVE HEART FAILURE)

Adult Health Nursing–I | NORCET 12 Preparation

Detailed Notes • Mnemonics • Clinical Cases • 25 MCQs

BSc Nursing NORCET Nursing Officer Exams Quick Revision

Learning Objectives

After completing this topic, students should be able to:

Define heart failure and understand its classification.
Explain the causes, risk factors and pathophysiology.
Differentiate left-sided, right-sided and biventricular heart failure.
Interpret EF categories, common investigations and clinical findings.
Understand major drug classes and emergency management principles.
Plan nursing assessment, interventions, patient education and evaluation.
Answer clinical scenario-based questions relevant to NORCET and Nursing Officer examinations.

📚 Clickable Table of Contents

Tap any topic to jump directly to that section.

1. Definition and Key Terms 2. Classification of Heart Failure 3. Causes and Risk Factors 4. Pathophysiology and Flowchart 5. Left-Sided vs Right-Sided HF 6. Signs and Symptoms 7. NYHA Functional Classification 8. Diagnostic Investigations 9. Acute Heart Failure and Pulmonary Edema 10. Medical Management and Drug Therapy 11. Nursing Management and Care Plan 12. Patient Education and Home Care 13. Complications 14. Mnemonics and Memory Tricks 15. NORCET Clinical Case Pearls 16. Last-Minute Revision Table 17. 30-Minute MCQ Test — 25 Questions

1. Definition and Key Terms

Heart failure (HF) is a clinical syndrome caused by a structural or functional abnormality of the heart, resulting in impaired ventricular filling or ejection of blood. The heart cannot meet the body's needs adequately without elevated filling pressures.

Exam alert: Heart failure does not mean that the heart has completely stopped. Cardiac arrest means the heart has stopped producing effective circulation; heart failure means the pumping or filling function is inadequate.

Important terminology

Preload: Ventricular filling/stretch at the end of diastole; clinically related to venous return and filling pressure.
Afterload: Resistance or pressure the ventricle must overcome to eject blood.
Contractility: Intrinsic strength of myocardial contraction.
Stroke volume (SV): Blood ejected by a ventricle per beat.
Cardiac output (CO): Blood pumped by the heart per minute.
Ejection fraction (EF): Percentage of end-diastolic ventricular blood volume ejected during systole.
Congestion: Fluid accumulation due to increased venous/capillary pressure and fluid retention.
Perfusion: Delivery of blood and oxygen to tissues.

Formula to remember:
Cardiac Output = Heart Rate × Stroke Volume
EF = (Stroke Volume ÷ End-Diastolic Volume) × 100

2. Classification of Heart Failure

A. According to the affected side

Type	Primary problem	Typical findings
Left-sided HF	Increased pressure backs up into pulmonary circulation	Dyspnea, orthopnea, crackles, pulmonary congestion
Right-sided HF	Increased pressure backs up into systemic veins	Raised JVP, dependent edema, hepatomegaly, ascites
Biventricular HF	Both ventricles are affected	Pulmonary and systemic congestion together

B. According to left ventricular ejection fraction

Category	EF	Key concept
HFrEF	40% or less	Reduced EF; systolic dysfunction is prominent
HFmrEF	41–49%	Mildly reduced EF
HFpEF	50% or more	Preserved EF; filling abnormalities are common

HFpEF still requires clinical evidence of heart failure and appropriate supporting evidence. A normal-range EF alone does not establish the diagnosis or exclude HF.

C. Other classifications

Acute HF: New or rapidly worsening heart failure symptoms.
Chronic HF: Long-standing condition requiring ongoing care.
Acute decompensated HF: Sudden or progressive worsening of established HF.
High-output HF: Cardiac output may be elevated but is insufficient for unusually high metabolic demand, for example in severe anemia or thyrotoxicosis.
Forward failure: Reduced effective tissue perfusion.
Backward failure: Blood and pressure accumulate behind the affected ventricle, producing congestion.

3. Causes and Risk Factors

Major causes

Coronary artery disease: Reduced blood supply damages myocardium.
Myocardial infarction: Loss of functioning myocardial tissue decreases pumping ability.
Hypertension: Increases afterload and promotes ventricular hypertrophy and remodeling.
Cardiomyopathy: Disease of the heart muscle.
Valvular heart disease: For example, aortic stenosis or mitral regurgitation.
Arrhythmias: Persistent tachyarrhythmias or severe bradyarrhythmias can impair cardiac output.
Myocarditis: Inflammation of the myocardium.
Congenital heart disease: Structural abnormalities present from birth.

Other contributing conditions

Diabetes mellitus, chronic kidney disease and obesity.
Severe anemia and thyroid disorders.
Alcohol-related cardiac damage and certain cardiotoxic medications.
Sleep-disordered breathing and other chronic illnesses.

Factors that may trigger acute worsening

Acute coronary syndrome or uncontrolled hypertension.
Arrhythmia, infection or pulmonary embolism.
Missed prescribed medicines.
Excessive sodium intake or inappropriate fluid intake in a susceptible patient.
Renal deterioration or medications that promote fluid retention, such as some NSAIDs.

Memory trick — “H-C-V-A” causes to remember:
H = Hypertension
C = Coronary artery disease
V = Valvular disease
A = Arrhythmia / cardiomyopathy-related abnormalities
This is a quick recall aid, not a complete list of causes.

4. Pathophysiology of Heart Failure

Underlying heart disease or excessive cardiac workload

↓

Impaired contraction and/or impaired ventricular relaxation

↓

Reduced effective cardiac output and/or raised filling pressure

↓

Sympathetic nervous system + RAAS + ADH activation

↓

Vasoconstriction + sodium/water retention

↓

Congestion, increased workload and ventricular remodeling

↓

Progressive HF and possible organ dysfunction

Explain each step

Step 1 — Initial injury: Ischemia, hypertension, valve disease or cardiomyopathy damages or overloads the heart.
Step 2 — Pump/filling impairment: The ventricle may contract weakly, relax poorly or experience both problems.
Step 3 — Reduced output / high filling pressure: Tissues may receive less effective blood flow while pressures behind the ventricle increase.
Step 4 — Sympathetic activation: Increases heart rate and vasoconstriction temporarily, but prolonged activation increases myocardial workload.
Step 5 — RAAS activation: Angiotensin II causes vasoconstriction; aldosterone promotes sodium and water retention.
Step 6 — ADH release: Promotes water retention.
Step 7 — Remodeling: Structural changes, hypertrophy and dilation can progressively impair function.

Memory trick — “SRA” in HF:
S = Sympathetic nervous system activation
R = Renin–angiotensin–aldosterone system activation
A = ADH-mediated water retention
Remember: these mechanisms initially compensate, but persistent activation can worsen HF.

5. Left-Sided vs Right-Sided Heart Failure

Feature	Left-sided HF	Right-sided HF
Congestion	Pulmonary circulation	Systemic venous circulation
Dyspnea	Common	Can occur, especially in biventricular HF
Orthopnea / PND	Characteristic symptoms	Less specific
Crackles	May occur with pulmonary congestion	Not a defining isolated feature
JVP	May be elevated in advanced or combined HF	Commonly elevated
Peripheral edema	May occur	Common
Hepatomegaly / ascites	Less characteristic	More characteristic
Common association	CAD, MI, hypertension	Left-sided HF or pulmonary hypertension / lung disease

Super-easy mnemonic — LEFT vs RIGHT
LEFT = LUNGS: breathlessness, orthopnea, PND, crackles.
RIGHT = REST of body: raised JVP, edema, enlarged liver, ascites.
Exam caution: Patients may have both left- and right-sided findings. Do not assume every patient fits a single pattern.

6. Signs and Symptoms

A. Respiratory manifestations

Dyspnea on exertion: Breathlessness during activity.
Orthopnea: Breathlessness when lying flat, relieved by sitting up.
Paroxysmal nocturnal dyspnea (PND): Sudden nighttime breathlessness that awakens the patient after a period of sleep.
Crackles: May indicate pulmonary congestion.
Cough: May worsen when lying down.
Pink frothy sputum: A possible sign of severe pulmonary edema; an emergency.

B. Systemic congestion

Raised jugular venous pressure.
Bilateral dependent pitting edema.
Hepatomegaly, abdominal discomfort and ascites.
Rapid weight gain due to fluid retention.

C. Reduced perfusion

Fatigue and exercise intolerance.
Cool extremities and weak pulse in severe cases.
Reduced urine output.
Dizziness, confusion or hypotension in severe low-output states.

Clinical clue: Edema and weight gain suggest fluid accumulation; cool extremities, confusion and oliguria can suggest poor perfusion. A patient may have congestion, low perfusion or both.

7. NYHA Functional Classification

Class	Description	Clinical example
Class I	No limitation of ordinary physical activity.	Ordinary activity does not cause undue dyspnea or fatigue.
Class II	Slight limitation.	Comfortable at rest; ordinary activity causes symptoms.
Class III	Marked limitation.	Comfortable at rest; less-than-ordinary activity causes symptoms.
Class IV	Symptoms at rest.	Physical activity increases discomfort; symptoms may be present at rest.

NYHA trick: “I–IV = Increasing limitation”
I = no limitation
II = ordinary activity causes symptoms
III = less-than-ordinary activity causes symptoms
IV = symptoms at rest

NYHA class describes functional limitation; it is not the same as the ACC/AHA stages of HF.

8. Diagnostic Investigations

Investigation	Purpose / important point
History and physical examination	Assesses symptoms, risk factors, volume status, perfusion, JVP, edema and lung sounds.
BNP / NT-proBNP	Supports diagnosis; interpret with clinical findings. Age, renal dysfunction, obesity and other conditions can affect levels.
Echocardiography	Evaluates EF, ventricular function, valves and structural abnormalities.
ECG	Assesses arrhythmias, ischemic changes and conduction abnormalities.
Chest X-ray	May show pulmonary congestion, pleural effusions or cardiomegaly.
Renal function tests	Urea and creatinine help assess renal function and guide treatment.
Serum electrolytes	Sodium and potassium monitoring is important during treatment.
CBC	May identify anemia or infection.
Troponin	Evaluates myocardial injury when clinically indicated.
Thyroid / iron studies and other tests	Selected according to clinical presentation and suspected cause.

Diagnostic mnemonic — “E-B-E-C”
E = Echocardiography
B = BNP / NT-proBNP
E = ECG
C = Chest X-ray
Add renal function, electrolytes, CBC and other tests as indicated.

NORCET pearl: Echocardiography assesses EF and cardiac structure/function. BNP or NT-proBNP supports diagnosis; neither should be interpreted alone.

9. Acute Heart Failure and Pulmonary Edema

Acute decompensated HF is new or worsening HF requiring prompt assessment and treatment. Acute pulmonary edema occurs when fluid accumulates in the lungs and can cause severe respiratory distress.

Warning signs

Severe breathlessness at rest or rapidly increasing respiratory effort.
Low oxygen saturation or cyanosis.
Pink frothy sputum or severe crackles.
Chest pain, confusion, hypotension or collapse.
Cool extremities and markedly reduced urine output suggesting poor perfusion.

Immediate care principles

Activate emergency/rapid response support according to local protocol.
Assess airway, breathing, circulation, consciousness and vital signs.
Position upright if tolerated and if hypotension does not make this unsafe.
Monitor oxygen saturation and cardiac rhythm.
Give oxygen when hypoxemia is present; ventilatory support may be required for severe respiratory distress.
Establish IV access and obtain prescribed investigations without delaying stabilization.
Administer prescribed IV loop diuretics when congestion is present.
Selected patients may need vasodilators, vasopressors or inotropes under close monitoring.
Identify and treat the precipitating cause.

Emergency exam point: Severe dyspnea, pink frothy sputum, cyanosis, chest pain, altered consciousness or signs of shock require urgent medical care. Do not delay emergency treatment for routine teaching or home remedies.

10. Medical Management and Drug Therapy

A. Four foundational drug classes for eligible patients with HFrEF

Class	Examples	Key nursing considerations
ARNI / ACE inhibitor / ARB	Sacubitril-valsartan; enalapril; valsartan	Monitor blood pressure, renal function and potassium. Do not combine an ACE inhibitor with ARNI; follow the required washout when switching from an ACE inhibitor to sacubitril-valsartan.
Evidence-based beta-blocker	Carvedilol, bisoprolol, metoprolol succinate	Monitor heart rate, blood pressure and symptoms. Initiate/titrate when stable and appropriate; not as an unsupervised response to acute decompensation.
Mineralocorticoid receptor antagonist (MRA)	Spironolactone, eplerenone	Monitor potassium and renal function; risk of hyperkalemia.
SGLT2 inhibitor	Dapagliflozin, empagliflozin	Can improve HF outcomes in eligible patients, including many without diabetes. Review renal function, volume status and relevant adverse-effect risks.

B. Diuretics

Loop diuretics: Furosemide and torsemide reduce fluid congestion.
Monitor urine output, daily weight, blood pressure, renal function and electrolytes.
Observe for dehydration, hypotension and electrolyte disturbances.

C. Other therapies in selected patients

Hydralazine plus nitrate in selected clinical situations.
Ivabradine for selected patients meeting heart-rate, rhythm and EF criteria.
Digoxin in selected patients; monitor toxicity risk and interactions when prescribed.
Anticoagulation only when there is an appropriate indication, such as atrial fibrillation with a relevant risk profile or venous thromboembolism—not routinely for every HF patient.
Device therapy such as an ICD or cardiac resynchronization therapy for eligible patients.

D. Important drug safety points

ACE inhibitors, ARBs, ARNIs and MRAs can affect potassium and renal function.
NSAIDs may worsen fluid retention or kidney function in susceptible patients.
Do not independently stop, start or alter HF medications.
Drug choice and dose depend on clinical status, contraindications, blood pressure, renal function and potassium.

HFrEF four pillars — “A-B-M-S”
A = ARNI (or ACE inhibitor/ARB when appropriate)
B = Evidence-based Beta-blocker
M = Mineralocorticoid receptor antagonist
S = SGLT2 inhibitor
Loop diuretics relieve congestion but are not a substitute for these foundational disease-modifying therapies when indicated.

11. Nursing Management and Care Plan

A. Assessment checklist

Assess respiratory rate, work of breathing, SpO₂, pulse and blood pressure.
Auscultate lungs for crackles and assess cough or sputum.
Assess JVP, edema, abdominal distension and skin perfusion.
Ask about orthopnea, PND, chest pain, fatigue and exercise tolerance.
Measure weight and review fluid balance when indicated.
Monitor urine output, renal function and electrolytes.
Review medication adherence, recent dietary changes and possible triggers.

B. Nursing diagnoses — individualize to assessment

Excess Fluid Volume related to impaired fluid regulation, as evidenced by edema or congestion.
Impaired Gas Exchange related to pulmonary congestion, if supported by findings.
Decreased Cardiac Output, when findings indicate impaired perfusion.
Activity Intolerance related to imbalance between oxygen supply and demand.
Deficient Knowledge regarding medication and self-care, if assessed.

C. Nursing interventions with rationale

Nursing intervention	Rationale
Place a breathless patient upright when tolerated.	May improve chest expansion and reduce respiratory discomfort.
Monitor vital signs, SpO₂ and respiratory status.	Identifies deterioration and response to treatment.
Measure daily weight consistently.	Helps detect changes in fluid status.
Record intake/output when clinically indicated.	Supports evaluation of fluid balance and diuretic response.
Assess edema, JVP and lung sounds.	Helps track congestion.
Administer prescribed medication and monitor effects.	Supports treatment while identifying adverse effects.
Monitor potassium, sodium and renal function as ordered.	Detects clinically important treatment-related changes.
Cluster care and allow rest periods.	Reduces fatigue and unnecessary exertion.
Escalate worsening dyspnea, hypotension, confusion, hypoxemia or oliguria.	May indicate acute deterioration or poor perfusion.

D. Expected outcomes

Improved breathing and oxygenation within the prescribed target.
Reduced congestion and edema.
Stable hemodynamics and adequate tissue perfusion.
Appropriate urine output and monitored renal/electrolyte status.
Patient demonstrates understanding of medication and the action plan.

Nursing mnemonic — “WEIGHT”
W = Weigh daily
E = Evaluate edema and effort of breathing
I = Intake/output monitoring as indicated
G = Give prescribed drugs safely
H = Hemodynamics, heart rate and oxygenation
T = Teach warning signs and treatment adherence

12. Patient Education and Home Care

Take medicines exactly as prescribed. Do not stop beta-blockers or other HF medicines without medical advice.
Follow the individualized sodium plan. Avoid excess salt and discuss packaged/processed foods.
Follow fluid restriction only if recommended for the individual patient.
Record weight daily at a consistent time, ideally after urination and before breakfast, using the same scale.
Follow the clinician's action plan for rapid weight gain. A commonly used alert is about 2–3 lb (0.9–1.4 kg) in 24 hours or 5 lb (2.3 kg) in a week; personal thresholds may differ.
Report increasing edema, breathlessness, new orthopnea or reduced exercise tolerance.
Attend follow-up visits and prescribed blood tests.
Stop smoking and discuss alcohol use with the treating team.
Follow an individualized activity/rehabilitation plan and balance activity with rest.
Ask a clinician or pharmacist before taking over-the-counter medicines, particularly NSAIDs.

Seek emergency help: Severe breathlessness at rest, chest pain, fainting, blue lips, confusion or pink frothy sputum should not wait for the next routine appointment.

13. Complications

Complication	Key concern
Acute pulmonary edema	Severe respiratory distress and hypoxemia.
Cardiogenic shock	Inadequate tissue perfusion and organ dysfunction.
Arrhythmias	May worsen cardiac output or cause sudden cardiac death.
Renal dysfunction	Reduced renal perfusion, venous congestion or treatment-related changes.
Hepatic congestion	May cause hepatomegaly and liver dysfunction.
Thromboembolism	Risk depends on coexisting conditions and individual clinical factors.
Repeated hospitalization	Reduced functional capacity and quality of life.

14. Mnemonics and Memory Tricks

1. LEFT vs RIGHT

LEFT = LUNGS — dyspnea, orthopnea, PND, crackles.

RIGHT = REST of body — raised JVP, dependent edema, hepatomegaly, ascites.

2. NYHA I–IV

“None → Ordinary → Less-than-ordinary → Rest”

I: No limitation.
II: Ordinary activity causes symptoms.
III: Less-than-ordinary activity causes symptoms.
IV: Symptoms at rest.

3. Four HFrEF pillars: A-B-M-S

ARNI/ACE inhibitor/ARB, evidence-based Beta-blocker, MRA, SGLT2 inhibitor.

4. Daily monitoring: “W-I-S-E”

W — Weight
I — Intake/output, when indicated
S — Symptoms and signs of congestion
E — Electrolytes and renal function as prescribed

5. Red flags: “B-C-C-S”

B — Breathlessness severe at rest
C — Chest pain
C — Cyanosis or confusion
S — Sputum pink and frothy / signs of shock

Memory aids support recall but do not replace clinical assessment or emergency protocols.

15. NORCET Clinical Case Pearls

Case 1: A patient has breathlessness on lying flat and bilateral lung crackles.

Think: Left-sided pulmonary congestion; assess severity and oxygenation.

Case 2: A patient has raised JVP, bilateral ankle edema and an enlarged tender liver.

Think: Systemic venous congestion, commonly associated with right-sided HF.

Case 3: A patient receiving loop diuretics develops dizziness and a low potassium level.

Think: Assess blood pressure, volume status, renal function and electrolytes; report and follow the prescribed plan.

Case 4: A patient with HF suddenly develops severe dyspnea, hypoxemia and pink frothy sputum.

Think: Suspect acute pulmonary edema. Initiate emergency assessment and escalation.

Case 5: A patient has an EF of 32%.

Think: This is within the HFrEF EF category. Evaluate the whole clinical picture and eligibility for guideline-directed therapy.

Case 6: A patient has symptoms consistent with HF and an EF of 58%.

Think: HFpEF may be present, but diagnosis requires appropriate clinical and supporting evidence; preserved EF alone is not diagnostic.

Case 7: A patient with HF develops cool extremities, confusion, hypotension and oliguria.

Think: Possible severe hypoperfusion or shock. Escalate urgently.

16. Last-Minute Revision Table

Question clue	High-yield answer
Breathlessness on lying flat	Orthopnea
Sudden nighttime breathlessness	Paroxysmal nocturnal dyspnea
Raised JVP and dependent edema	Systemic venous congestion
HFrEF	EF ≤40%
HFmrEF	EF 41–49%
HFpEF	EF ≥50% with supporting HF evidence
Key structural assessment	Echocardiography
Biomarkers supporting HF diagnosis	BNP / NT-proBNP
Four HFrEF foundational classes	ARNI/ACE inhibitor/ARB, beta-blocker, MRA, SGLT2 inhibitor
Fluid congestion relief	Loop diuretics, when indicated
Important monitoring	Weight, fluid status, renal function, electrolytes
Severe dyspnea + pink frothy sputum	Suspect acute pulmonary edema; emergency care

↑ Back to Top

17. NORCET 12 Practice Test — Heart Failure

Instructions: 25 single-best-answer questions • 30 minutes • One question at a time.

Choose an option, use Previous and Next to navigate, and press Submit Test to see your score and explanations. The test submits automatically when time expires.

Time Remaining: 30:00

Question 1 of 25

Educational material for nursing examination preparation. Clinical management must follow current guidelines, local protocols and individualized clinician assessment.